Cardiac Surgery Department, Institute for Cardiovascular Diseases "Dedinje", 11040 Belgrade, Serbia.
Department of Surgery, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Medicina (Kaunas). 2023 May 26;59(6):1032. doi: 10.3390/medicina59061032.
: There is a lack of data about the survival of patients after the implantation of sutureless relative to stented bioprostheses in middle-income settings. The objective of this study was to compare the survival of people with isolated severe aortic stenosis after the implantation of sutureless and stented bioprostheses in a tertiary referral center in Serbia. : This retrospective cohort study included all people treated for isolated severe aortic stenosis with sutureless and stented bioprostheses from 1 January 2018 to 1 July 2021 at the Institute for Cardiovascular Diseases "Dedinje". Demographic, clinical, perioperative and postoperative data were extracted from the medical records. The follow-up lasted for a median of 2 years. : The study sample comprised a total of 238 people with a stented (conventional) bioprosthesis and 101 people with a sutureless bioprosthesis (Perceval). Over the follow-up, 13.9% of people who received the conventional and 10.9% of people who received the Perceval valve died ( = 0.400). No difference in the overall survival was observed ( = 0.797). The multivariate Cox proportional hazard model suggested that being older, having a higher preoperative EuroScore II, having a stroke over the follow-up period and having valve-related complications were independently associated with all-cause mortality over a median of 2 years after the bioprosthesis implantation. : This research conducted in a middle-income country supports previous findings in high-income countries regarding the survival of people with sutureless and stented valves. Survival after bioprosthesis implantation should be monitored long-term to ensure optimum postoperative outcomes.
在中低收入国家,关于无缝线与带支架生物瓣植入后患者存活率的数据较为缺乏。本研究的目的是比较塞尔维亚一家三级转诊中心中孤立性重度主动脉瓣狭窄患者在植入无缝线与带支架生物瓣后的存活率。
本回顾性队列研究纳入了自 2018 年 1 月 1 日至 2021 年 7 月 1 日期间在心血管疾病研究所“Dedinje”接受无缝线与带支架生物瓣治疗的所有孤立性重度主动脉瓣狭窄患者。从病历中提取了人口统计学、临床、围手术期和术后数据。随访时间中位数为 2 年。
研究样本共包括 238 名接受带支架(传统)生物瓣治疗的患者和 101 名接受无缝线生物瓣(Perceval)治疗的患者。随访期间,接受传统生物瓣治疗的患者中有 13.9%和接受 Perceval 瓣治疗的患者中有 10.9%死亡( = 0.400)。未观察到总体生存率的差异( = 0.797)。多变量 Cox 比例风险模型提示,年龄较大、术前 EuroScore II 较高、随访期间发生中风以及发生与瓣膜相关的并发症与植入生物瓣后 2 年的全因死亡率独立相关。
这项在中低收入国家进行的研究支持了高收入国家先前关于无缝线与带支架瓣膜患者存活率的研究结果。应长期监测生物瓣植入后的存活率,以确保获得最佳的术后结果。